Comfortis
Withdrawn
spinosad
Medicine
Veterinary
Withdrawn
The marketing authorisation for Comfortis has been withdrawn at the request of the marketing authorisation holder
Treatment and prevention of flea infestations (Ctenocephalides felis).
The preventive effect against re-infestations is a result of the adulticidal activity and the reduction in egg production and persists for up to 4 weeks after a single administration of the product.
The veterinary medicinal product can be used as part of a treatment strategy for the control of flea allergy dermatitis (FAD).